Navigation Links
Spectros Corporation Introduces Continuum®, a Broadband Infrared Sensor for Brain and Gut Oximetry
Date:6/13/2011

PORTOLA VALLEY, Calif., June 13, 2011 /PRNewswire/ -- Spectros Corporation announced Continuum®, a proprietary broadband near infrared illuminator sensor under development for several years and now in testing. This sensor represents the newest generation and state-of-the-art for medical sensor probes. Continuum is a solid-state illuminator that creates light of many wavelengths, called broadband, which allows for noninvasive analysis of various components in tissue and blood, including different types of hemoglobin, fat content, and water content. The new sensor is protected by a broad family of issued patents, and will be incorporated into the Company's flagship T-Stat Oximeter and Analysis platforms.

"Broadband NIRS illumination is the key to detecting more compounds in the tissue," notes CEO David Benaron. "This will substantially increase the accuracy of NIRS measurements in tissue, just as the broadband T-Stat VLS oximeter has established market leading accuracy and reproducibility in clinical studies".

Clinical application of Continuum sensors incorporating the broadband NIRS illuminator will allow placement on the patient's head to monitor the brain, on the abdomen to monitor the gut, and over muscle to monitor local perfusion. Early clinical studies suggest the device may have use in noninvasive detection of necrotizing enterocolitis, a gut disease of newborns; in contrast, standard NIRS oximeters suffer from interference from water, stool, and fat when placed over the abdomen.

Spectros T-Stat and Continuum Oximeters are currently the only broadband tissue oximeters on the market in the U.S. and Europe. T-Stat and Continuum compete in the marketplace with INVOS® oximeters marketed by Covidien, and FORE-SIGHT® oximeters marketed by CAS. In reconstructive surgery, T-Stat competes with oximeters marketed by ViOptix. An expanded array of probes, including Continuum® cerebral probes are currently in testing, pending FDA
'/>"/>

SOURCE Spectros
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
2. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
3. Spectros Corp. Enters Into Optical Biotechnology Patent Sale Agreement With Philips Electronics N.V.
4. Spectros Presents at the Pediatric Academic Societies (PAS) National Conference 2010
5. ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
6. Spectros Presents New Clinical Studies Using T-Stat VLS Tissue Oximeter at Anesthesiology 2010
7. Spectros White LED Patent Scope Affirmed In U.S. Patent Office Reexamination
8. Spectros Corporation Sales and Licensing Revenue Up 32% in 2010
9. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
10. CEL-SCI Corporation Releases Letter to Shareholders
11. Alfacell Corporation to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... QPID Health , a leader in clinical intelligence software, today ... and their first West Coast location in San ... in Boston , and will house product development, ... Southern California office will be located at 1000 ... demands of customers nationwide.  Both new locations will be operational ...
(Date:9/16/2014)... Resources Group finds that the rheumatoid arthritis (RA) disease-modifying antirheumatic drug ... billion in 2023 in the United States , ... Italy , Spain , the ... TNF-alpha inhibitors will remain the leading drug class in both sales ... constrained and patient shares will decline due to the uptake of ...
(Date:9/16/2014)... 16, 2014  Formex, LLC ("Formex"), a ... Mr. Greg Weilersbacher joined Formex as Director of ... Greg Weilersbacher has over ... expertise in Quality Assurance, Facility Validation, GMP ... brings to Formex a diverse wealth of ...
Breaking Medicine Technology:QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 3Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2
... US Phase II Clinical Trials for Organ Transplantation, ... announces positive Phase I clinical results for,its transplantation ... clinical trials for organ transplantation. , Today LifeCycle ... I clinical trial program of LCP-Tacro, a,proprietary, once-daily ...
... Hemispherx Biopharma, Inc.,(AMEX: HEB), a biopharmaceutical company ... new drug entities for pandemic,disease threats, announced ... therapeutic product candidate Alferon-LDO in,combating highly pathogenic ... Alferon-LDO is a low-dose experimental oral formulation,of ...
Cached Medicine Technology:LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 2Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 3Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 4
(Date:9/16/2014)... (PRWEB) September 16, 2014 SAMHSA, the federal ... mission a reduction of the impact of substance abuse and ... on the SAMHSA website in September is National Recovery Month, ... honor the gains made by those individuals in recovery. ... to addiction treatment in an effort to help those with ...
(Date:9/16/2014)... Using a pain clinic as a testing ground, researchers ... first popularized by Toyota in Japan can substantially reduce ... interns and residents. , In a report on the ... Medicine , the researchers adopted the so-called "Just-in-Time" training ... service industries to stem waste and keep complicated operations ...
(Date:9/16/2014)... R.I. (PRWEB) September 16, 2014 As ... Sunday, Sept. 14, through Saturday, Sept. 20, Amica ... sure children are safe and secure while in the ... the National Traffic Highway Safety Administration (NHTSA), 20 ... not read the instruction manual when installing child restraints. ...
(Date:9/16/2014)... 2014 Regulatory intelligence (RI), the ... has become a crucial skill for regulatory professionals ... sectors. Regulatory Intelligence 101 , new from ... serves as an essential guide to the basics ... examines available regulatory intelligence tools, both free and ...
(Date:9/16/2014)... Illegal drug use among teens in the United States is ... Encouragingly, the new study also found that alcohol use, ... people between the ages of 12 and 17 also dropped ... people aged 12 and older across the United States revealed ... among this age group also dropped from 8.9 percent to ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Booklet Offers Tips During Recovery Month 2Health News:Narconon Arrowhead Booklet Offers Tips During Recovery Month 3Health News:Patients waiting too long to see doctor? Try 'just-in-time' management methods, researchers urge 2Health News:Amica Offers Tips During Child Passenger Safety Week 2Health News:RAPS Publishes Regulatory Intelligence 101 Book 2Health News:Fewer U.S. Teens Using Illegal Drugs and Alcohol, Report Finds 2
... apply the chemicals, study shows , THURSDAY, June 18 ... the normal risk of developing a precancerous blood disorder, ... undetermined significance) and characterized by an abnormal level of ... can lead to multiple myeloma, a cancer of the ...
... ... term, the continent’s healthcare leadership must be strengthened and expanded at the individual, institutional, ... ... -- To improve health outcomes in Africa over the long term, the continent’s healthcare ...
... up at night worrying whether they are going to develop diabetes ... middle age is a lifetime away. As it ... School of Medicine have found that young adults (18 to 30 ... treadmill test -- are two to three times more likely to ...
... Arnhem, June 2009 The 4th ESU Master class ... the European School of Urology (ESU) on 27-28 June ... The format consists of three modules. Module 1 is ... ,Immunotherapy and targeted therapies, and module 3 ,Systemic cytotoxic ...
... (OTC Bulletin Board: BHRT) a company committed to delivering ... treat heart failure and cardiovascular diseases announced today that ... systems at the American Association of Heart Failure Nurses ... place from June 25 - 27, 2009 at the ...
... , ... present never-before released results from two annual surveys at the upcoming DIA Meeting in ... ... for clinical trials information, will present never-before released results from two annual surveys aimed ...
Cached Medicine News:Health News:Pesticides Linked to Blood Disorder 2Health News:Accordia Global Health Foundation Calls for Greater Investment to Build African Healthcare Leadership 2Health News:Accordia Global Health Foundation Calls for Greater Investment to Build African Healthcare Leadership 3Health News:Aerobically unfit young adults on road to diabetes in middle age 2Health News:4th ESU master class on medical treatment for urological cancer held in Barcelona, Spain 2Health News:Bioheart to Introduce Improved Heart Failure Monitoring Systems at Heart Failure Nurses Annual Meeting 2Health News:Bioheart to Introduce Improved Heart Failure Monitoring Systems at Heart Failure Nurses Annual Meeting 3Health News:CenterWatch to Introduce Key Findings from Surveys on Physician Referrals to Clinical Trials and Clinical Trial Volunteer Experiences at DIA Meeting 2
Lombart clip-on occluder...
9 inch double ended with one end black and the other end with 49 holes...
Double Ended Occluders...
Long handle occluders are approximately 9 inches long....
Medicine Products: